235 results on '"Wu, Qiuji"'
Search Results
2. The effects of immune checkpoint inhibitors vs. chemotherapy combined with brain radiotherapy in non-small cell lung cancer patients with brain metastases
Catalog
Books, media, physical & digital resources
3. Improved outcomes of palliative radiotherapy combined with immune checkpoint inhibitors in recurrent or metastatic cervical cancers
4. Lymph node metastasis in cancer: Clearing the clouds to see the dawn
5. In situ customized apolipoprotein B48-enriched protein corona enhances oral gene delivery of chitosan-based nanoparticles
6. Research trends of targeted therapy for cholangiocarcinoma from 2003 to 2022: a bibliometric and visual analysis
7. Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study
8. Determination of optimum number of cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a single-center retrospective study
9. The correlation of CD70 in immune characteristics and drug therapy of pan-cancer
10. A shear-thinning, ROS-scavenging hydrogel combined with dental pulp stem cells promotes spinal cord repair by inhibiting ferroptosis
11. Optimal induction chemotherapy regimen for locoregionally advanced nasopharyngeal carcinoma: an update Bayesian network meta-analysis
12. Correction: Research trends of targeted therapy for cholangiocarcinoma from 2003 to 2022: a bibliometric and visual analysis
13. PARP inhibitor plus radiotherapy reshapes an inflamed tumor microenvironment that sensitizes small cell lung cancer to the anti-PD-1 immunotherapy
14. Clinical Features and Prognostic Factors of Adenoid Cystic Carcinoma of Head and Neck
15. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts
16. Study on the prognosis, immune and drug resistance of m6A-related genes in lung cancer
17. Versatile subtypes of pericytes and their roles in spinal cord injury repair, bone development and repair
18. Author Correction: Gelatine nanostructured lipid carrier encapsulated FGF15 inhibits autophagy and improves recovery in spinal cord injury
19. Alginate self-adhesive hydrogel combined with dental pulp stem cells and FGF21 repairs hemisection spinal cord injury via apoptosis and autophagy mechanisms
20. Survival and prognosis of lung large cell neuroendocrine carcinoma
21. Cost-Effectiveness Analysis of First-Line Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma in the United States
22. The role of non-apoptotic cell death in the treatment and drug-resistance of digestive tumors
23. Hypoxia response element-directed expression of bFGF in dental pulp stem cells improve the hypoxic environment by targeting pericytes in SCI rats
24. NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy
25. Cost-effectiveness analysis of durvalumab plus tremelimumab as first-line therapy in patients with unresectable hepatocellular carcinoma.
26. Promising first‐line immuno‐combination therapies for unresectable hepatocellular carcinoma: A cost‐effectiveness analysis.
27. Whole-brain radiation therapy plus simultaneous integrated boost for brain metastases from breast cancers.
28. The causal effect of atopic dermatitis on lung cancer: A Mendelian randomization study.
29. Cost-effectiveness of Capecitabine + Irinotecan Versus Leucovorin + Fluorouracil + Irinotecan in the Second-line Treatment of Metastatic Colorectal Cancer in China
30. Targeting acute myeloid leukemia stem cells: Current therapies in development and potential strategies with new dimensions
31. Cost-effectiveness analysis of gemcitabine plus cisplatin versus docetaxel, cisplatin and fluorouracil for induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma
32. First-line fulvestrant plus anastrozole for hormone-receptor-positive metastatic breast cancer in postmenopausal women: a cost-effectiveness analysis
33. Oral pH value predicts the incidence of radiotherapy related caries in nasopharyngeal carcinoma patients
34. Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis
35. Nerve growth factor (NGF) with hypoxia response elements loaded by adeno-associated virus (AAV) combined with neural stem cells improve the spinal cord injury recovery
36. Comprehensive analysis of EMT-related genes and lncRNAs in the prognosis, immunity, and drug treatment of colorectal cancer
37. HIV-1 Envelope Overcomes NLRP3-Mediated Inhibition of F-Actin Polymerization for Viral Entry
38. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: A cost-effectiveness analysis
39. TPP1 is associated with risk of advanced precursors and cervical cancer survival.
40. AAV2-mediated and hypoxia response element-directed expression of bFGF in neural stem cells showed therapeutic effects on spinal cord injury in rats
41. Macrophage biology plays a central role during ionizing radiation-elicited tumor response
42. Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients
43. Gelatine nanostructured lipid carrier encapsulated FGF15 inhibits autophagy and improves recovery in spinal cord injury
44. Comparison of Definitive Radiotherapy-Based Treatment and Surgical-Based Treatment for Locally Advanced Head and Neck Soft Tissue Sarcoma.
45. Ataxia telangiectasia mutated kinase inhibition promotes irradiation‐induced PD‐L1 expression in tumour‐associated macrophages through IFN‐I/JAK signalling pathway.
46. The impact of the COVID-19 pandemic on head and neck cancer patients
47. Identification of Two m6A Readers YTHDF1 and IGF2BP2 as Immune Biomarkers in Head and Neck Squamous Cell Carcinoma.
48. Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
49. Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemia.
50. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.